Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease, Nature, vol.386, pp.395-399, 1997. ,
Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration, J Neurosci, vol.22, pp.4478-4486, 2002. ,
Neuroprotective gene therapy for Huntington's disease, using polymerencapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study, Hum Gene Ther, vol.15, pp.968-975, 2004. ,
Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients, Nat Med, vol.2, pp.696-699, 1996. ,
Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants, Proc Natl Acad Sci, vol.103, pp.3896-3901, 2006. ,
CNTF: a target therapeutic for obesity-related metabolic disease?, J Mol Med, vol.86, pp.353-361, 2008. ,
Activation of astrocytes by CNTF induces metabolic plasticity and increases resistance to metabolic insults, J Neurosci, vol.27, pp.7094-7104, 2007. ,
Ciliary neurotrophic factor activates astrocytes, redistributes their glutamate transporters GLAST and GLT-1 to raft microdomains, and improves glutamate handling in vivo, J Neurosci, vol.26, pp.5978-5989, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00088896
Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging, J Neurosci, vol.32, pp.10809-10818, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02110993
Estimation of metabolite concentrations from localized in vivo proton NMR spectra, Magn Reson Med, vol.30, pp.672-679, 1993. ,
Postmortem degradation of N-acetyl aspartate and N-acetyl aspartylglutamate: an HPLC analysis of different rat CNS regions, Neurochem Res, vol.26, pp.695-702, 2001. ,
Neuroprotective effect of a CNTFexpressing lentiviral vector in the quinolinic acid rat model of Huntington's disease, Neurobiol Dis, vol.8, pp.433-446, 2001. ,
Magnetic resonance imaging of glutamate, Nat Med, vol.18, pp.302-306, 2012. ,
N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology, Prog Neurobiol, vol.81, pp.89-131, 2007. ,
Ciliary neurotrophic factor protects striatal neurons against excitotoxicity by enhancing glial glutamate uptake, PLoS One, vol.5, p.8550, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00848866
Dosedependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease, Hum Gene Ther, vol.13, pp.1981-1990, 2002. ,
Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease, J Neurosci, vol.16, pp.5168-5181, 1996. ,
Intracompartmental delivery of CNTF as therapy for Huntington's disease and retinitis pigmentosa, Curr Gene Ther, vol.6, pp.147-159, 2006. ,
Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease, Hum Gene Ther, vol.11, pp.1177-1187, 2000. ,
N-Acetylaspartate reductions in brain injury: impact on post-injury neuroenergetics, lipid synthesis, and protein acetylation, Front Neuroenergetics, vol.5, p.11, 2013. ,